Labcorp Announces Executive Changes and Shareholder Votes

Ticker: LH · Form: 8-K · Filed: 2025-05-20T00:00:00.000Z

Sentiment: neutral

Topics: executive-changes, shareholder-vote, financials

Related Tickers: LH

TL;DR

Labcorp's 8-K drops: exec changes, votes, and financials filed. Big day for the company.

AI Summary

Labcorp Holdings Inc. announced on May 15, 2025, several key executive changes and compensatory arrangements. The company also reported on matters submitted to a vote of security holders and filed financial statements and exhibits. These events are detailed in their Form 8-K filing.

Why It Matters

Changes in executive leadership and compensation can signal shifts in company strategy or performance, while shareholder votes impact corporate governance.

Risk Assessment

Risk Level: low — The filing is a routine current report detailing executive changes, shareholder votes, and financial filings, with no immediate indication of significant financial distress or operational disruption.

Key Numbers

Key Players & Entities

FAQ

What specific executive positions were affected by the changes reported in this 8-K?

The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but the specific names and positions are not detailed in the provided excerpt.

What were the key matters submitted to a vote of security holders?

The filing states that 'Submission of Matters to a Vote of Security Holders' is an item reported, but the specific proposals voted upon are not detailed in this excerpt.

What financial statements and exhibits are included with this filing?

The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these statements and exhibits is not provided in the excerpt.

When was the earliest event reported in this Form 8-K?

The earliest event reported in this Form 8-K was on May 15, 2025.

What is Labcorp's principal executive office address?

Labcorp's principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.

From the Filing

0000920148-25-000069.txt : 20250520 0000920148-25-000069.hdr.sgml : 20250520 20250520074534 ACCESSION NUMBER: 0000920148-25-000069 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250515 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250520 DATE AS OF CHANGE: 20250520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 25966176 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20250515.htm 8-K lh-20250515 0000920148 false 0000920148 2025-05-15 2025-05-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 15, 2025 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-11353 99-2588107 (State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 358 South Main Street   Burlington , North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act: Title of each class Trading Symbol Name of exchange on which registered Common Stock, $0.10 par value LH New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).              Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 15, 2025, the shareholders of Labcorp Holdings Inc. (the “Company”) approved the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan (the “2025 Omnibus Incentive Plan”) and the Labcorp Holdings Inc. 2025 Employee Stock Purchase Plan (the “2025 ESPP”) at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”). Descriptions of the

View on Read The Filing